Article
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Cancer research - 15 Oct 2006
Goldstein Alisa M, Chan May, Harland Mark, Gillanders Elizabeth M, Hayward Nicholas K, Avril Marie-Francoise, Azizi Esther, Bianchi-Scarra Giovanna, Bishop D Timothy, Bressac-de Paillerets Brigitte, Bruno William, Calista Donato, Cannon Albright Lisa A, Demenais Florence, Elder David E, Ghiorzo Paola, Gruis Nelleke A, Hansson Johan, Hogg David, Holland Elizabeth A, Kanetsky Peter A, Kefford Richard F, Landi Maria Teresa, Lang Julie, Leachman Sancy A, Mackie Rona M, Magnusson Veronica, Mann Graham J, Niendorf Kristin, Newton Bishop Julia, Palmer Jane M, Puig Susana, Puig-Butille Joan A, de Snoo Femke A, Stark Mitchell, Tsao Hensin, Tucker Margaret A, Whitaker Linda, Yakobson Emanuel
Abstract excerpt
GenoMEL, comprising major familial melanoma research groups from North America, Europe, Asia, and Australia has created the largest familial melanoma sample yet available to characterize mutations in the high-risk melanoma susceptibility genes CDKN2A/alternate reading frames (ARF), which encodes p16 and p14ARF, and CDK4 and to evaluate their relationship with pancreatic cancer (PC), neural system tumors (NST),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.